… structural correlates of SARS-CoV-2 neutralization, we solved eight new structures of distinct
COVID-19 human neutralizing antibodies 5 in complex with the SARS-CoV-2 spike trimer …

… The frequency distributions of human V genes in anti-SARS-CoV-2 antibodies from this
study were compared to 131,284,220 previously generated IgH and IgL sequences 53 and …

… that have antibody-escape mutations and the potential for antibody-… representative
SARS-CoV-2 neutralizing antibodies that have … of COVID-19 preventive or therapeutic antibodies. …

… infected with SARS-CoV-2. We identified antibodies that potently neutralize SARS-CoV-2; …
Unexpectedly, the anti-SARS-CoV-2 antibodies and the infected plasma did not cross-react …

… encoding the SARS-CoV-2 spike (S) … SARS-CoV-2 [8, 9]. It has been highlighted in a study
that there is a wide phenotypic variation in human antibody responses against SARS-CoV-2 […

… to detect SARS-CoV-2 antibodies. Both assays were used for clinical COVID-19 serology
testing. Method validation was performed to demonstrate equivalence of the 2 assays in …

… the characteristics of the antibody response, its dynamics over time, … describing the antibody
response to SARS-CoV-2 published … Literature on antibody responses to SARS-CoV-2 is of …

… for the presence of antibodies, the extent to which SARS-CoV-2 antibodies provide future …
Experimental evidence shows neutralisation with certain SARS-CoV-2 antibodies, and inferred …

… Our findings have relevance to the use of monoclonal antibody to treat or prevent SARS-CoV-2.
Both B.1.1.7 and B.1.351 are resistant to neutralization by monoclonal antibodies …

… PCR-confirmed infected with SARS-CoV-2. Finally, we longitudinally measured hCoV and
SARS-CoV-2 antibodies in the serum of hospitalized COVID-19 patients. Our studies indicate …